Steven C. Crouse - 01 Mar 2026 Form 3 Insider Report for BIO-TECHNE Corp (TECH)

Role: President - Diag & Spatial Bi
Signature: /s/ Andrew Nick as Attorney-in-Fact for Steven C. Crouse pursuant to Power of Attorney filed herewith.
Issuer symbol: TECH
Transactions as of: 01 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 04 Mar 2026, 18:47:54 UTC
Previous filing: 18 Jun 2025
Next filing: 04 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Crouse Steven C.	President - Diag & Spatial Bi	614 MCKINLEY PLACE NE, MINNEAPOLIS	/s/ Andrew Nick as Attorney-in-Fact for Steven C. Crouse pursuant to Power of Attorney filed herewith.	04 Mar 2026	0002065241

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TECH	Common Stock						5,894	01 Mar 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TECH	Restricted Stock Units							01 Mar 2026	Common Stock	1,588		Direct	F1, F2
holding	TECH	Restricted Stock Units							01 Mar 2026	Common Stock	1,800		Direct	F1, F3
holding	TECH	Restricted Stock Units							01 Mar 2026	Common Stock	1,379		Direct	F1, F4
holding	TECH	Restricted Stock Units							01 Mar 2026	Common Stock	3,737		Direct	F1, F5
holding	TECH	Restricted Stock Units							01 Mar 2026	Common Stock	6,529		Direct	F1, F6
holding	TECH	Stock Option (right to buy)							01 Mar 2026	Common Stock	3,856	$97.13	Direct	F7
holding	TECH	Stock Option (right to buy)							01 Mar 2026	Common Stock	19,032	$120.46	Direct	F7
holding	TECH	Stock Option (right to buy)							01 Mar 2026	Common Stock	24,560	$94.52	Direct	F8
holding	TECH	Stock Option (right to buy)							01 Mar 2026	Common Stock	12,649	$84.61	Direct	F9
holding	TECH	Stock Option (right to buy)							01 Mar 2026	Common Stock	7,327	$73.46	Direct	F10
holding	TECH	Stock Option (right to buy)							01 Mar 2026	Common Stock	17,133	$74.91	Direct	F11
holding	TECH	Stock Option (right to buy)							01 Mar 2026	Common Stock	5,434	$48.61	Direct	F12
holding	TECH	Stock Option (right to buy)							01 Mar 2026	Common Stock	19,151	$53.60	Direct	F13

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2	794 restricted stock units vest on 5/1/2026 and 5/1/2027.
F3	600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028.
F4	1,379 restricted stock units vest on 8/15/2026.
F5	1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027.
F6	2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027.
F7	100% vested.
F8	Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
F9	Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025.
F10	Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027.
F11	Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026.
F12	Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029.
F13	Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028.